TITLE

Recent advances in Clostridium difficiIe-associated disease

AUTHOR(S)
Monaghan, T.; Boswell, T.; Mahida, Y. H.
PUB. DATE
June 2008
SOURCE
Gut;Jun2008, Vol. 57 Issue 6, p850
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The main purpose of this article is to review recent developments in the management of acute and recurrent Clostridium difficile-associated disease, with consideration of existing and new antibiotic and non-antibiotic agents for treatment. Details of the current developmental stage of new agents are provided and the role of surgery in the management of severe disease is discussed. Infection control measures considered comprise prudent use of antimicrobials, prevention of cross-infection and surveillance. Other topics that are covered include the recent emergence of an epidemic hypervirulent strain, pathogenesis, clinical presentation and approaches to rapid diagnosis and assessment of the colonic disease.
ACCESSION #
32531222

 

Related Articles

  • Clostridium difficile Colitis Following Antibiotic Prophylaxis for Dental Procedures. . Bombassaro, Anne Marie; Wetmore, Stephen J.; John, Michael A. // Journal of the Canadian Dental Association;Jan2001, Vol. 67 Issue 1, p20 

    Clostridium difficile-induced diarrhea and colitis are common complications of therapeutic courses of antibiotics in the hospital setting. We report a case of Clostridium difficile colitis following antibiotic prophylaxis for endocarditis prior to dental procedures in the community setting. The...

  • OPTIMIZING THE USE OF Carbapenems IN THE FACE OF INCREASING GRAM-NEGATIVE RESISTANCE.  // Formulary;Jul2007 Supplement, Vol. 42, p3 

    The article focuses on the clinical and economic impact of carbapenems, an antibiotic with a broad spectrum of antibacterial activity, in the U.S. The drug possesses a broad spectrum of activity that threatens the superinfections by fungi and resistant bacteria including the collateral damage in...

  • Collective action and individual choice: rethinking how we regulate narcotics and antibiotics. Anomaly, Jonny // Journal of Medical Ethics;Dec2013, Vol. 39 Issue 12, p752 

    Governments across the globe have squandered treasure and imprisoned millions of their own citizens by criminalising the use and sale of recreational drugs. But use of these drugs has remained relatively constant, and the primary victims are the users themselves. Meanwhile, antimicrobial drugs...

  • The Chemotactic Response of Human Granulocytes to Clostridium difficile Toxin A is Age Dependent. Triadafilopoulos, George; Shah, Mukesh H.; Pothoulakis, Charalambos // American Journal of Gastroenterology;Oct1991, Vol. 86 Issue 10, p1461 

    Elderly patients are at high risk for developing diarrhea and colitis as a complication of antimicrobial therapy. Clostridium difficile, the causative agent of antibiotic-associated diarrhea and colitis produces an enterotoxin (toxin A) and a cytotoxin (toxin B). Of these two exotoxins, toxin A...

  • Role of Klebsiella oxytoca in Antibiotic-Associated Diarrhea. Zollner-Schwetz, Ines; Högenauer, Christoph; Joainig, Martina; Weberhofer, Paul; Gorkiewicz, Gregor; Valentin, Thomas; Hinterleitner, Thomas A.; Krause, Robert // Clinical Infectious Diseases;11/1/2008, Vol. 47 Issue 9, pe74 

    Background. Klebsiella oxytoca was recently shown to be the causative agent of antibiotic-associated hemorrhagic colitis. Because it is unclear whether K. oxytoca also causes nonhemorrhagic antibiotic-associated diarrhea, our study investigated a possible association between K. oxytoca and that...

  • Clostridium difficile exposure as an insidious source of infection in healthcare settings: an epidemiological model. Yakob, Laith; Riley, Thomas V.; Paterson, David L.; Clements, Archie C. A. // BMC Infectious Diseases;2013, Vol. 13 Issue 1, p1 

    Background: Clostridium difficile is the leading cause of infectious diarrhea in hospitalized patients. Its epidemiology has shifted in recent years from almost exclusively infecting elderly patients in whom the gut microbiota has been disturbed by antimicrobials, to now also infecting...

  • A staff nurse's perspective of infection control problems. Grainger, Michelle // British Journal of Nursing;9/22/2005, Vol. 14 Issue 17, p912 

    Earlier this month astonishing figures causing major concern were released from the Department of Health (DoH) showing the number of cases of Clostridium difficile in the over 65s in hospitals in England. This article focuses upon what is already known about infection control and concludes that...

  • A case-control study of community-associated Clostridium difficile infection. M. H. Wilcox; L. Mooney; R. Bendall; C. D. Settle; W. N. Fawley // Journal of Antimicrobial Chemotherapy (JAC);Aug2008, Vol. 62 Issue 2, p388 

    Objectives The aim of this study was to determine the incidence of and risk factors for community-associated Clostridium difficile infection (CDI). Methods Prospective surveillance of community-derived faecal samples for C. difficile cytotoxin, followed by a questionnaire-based...

  • Unnecessary use of fluoroquinolone antibiotics in hospitalized patients. Werner, Nicole L.; Hecker, Michelle T.; Sethi, Ajay K.; Donskey, Curtis J. // BMC Infectious Diseases;2011, Vol. 11 Issue 1, p187 

    Background: Fluoroquinolones are among the most commonly prescribed antimicrobials and are an important risk factor for colonization and infection with fluoroquinolone-resistant gram-negative bacilli and for Clostridium difficile infection (CDI). In this study, our aim was to determine current...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics